© 1989 by Oxford University Press
Journal of the National Cancer Institute, Vol. 81, No. 24, 1913-1917,
December 20, 1989
© 1989 Oxford University Press
Detection of the Tumor-Associated Glycoprotein Antigen (TAG-72) in Premalignant Lesions of the Colon
1Department of Surgery, Laboratory of Cancer Biology, New England Deaconess Hospital and Harvard Medical School Boston, MA
2Mallory Institute of Pathology and Boston University School of Medicine Boston, MA
*Correspondence to: Dr. Barbara C. Wolf, Laboratory of Cancer Biology, New England Deaconess Hospital, 50 Binney St., Boston, MA 02115
We used monoclonal antibody B72.3 to study the expression of the colorectal carcinoma-associated antigen TAG-72 in premalignant colonic lesions with the immunoperoxidase technique. This antigen, which is rarely detectable in the normal colonic epithelium, was expressed in 13 of 19 adenomas with moderate to severe dysplasia and nine of nine cases of inflammatory bowel disease. The antibody reacted with the normal-appearing mucosa adjacent to a carcinoma in 10 of 12 cases, although only eight of the tumors expressed the antigen. The expression of the TAG-72 antigen in the colonic epithelium may be an early marker of malignant transformation. (J Natl Cancer Inst 81: 19131917, 1989).
This article has been cited by other articles:
![]() |
M. G. Rosenblum, C. F. Verschraegen, J. L. Murray, A. P. Kudelka, J. Gano, L. Cheung, and J. J. Kavanagh Phase I Study of 90Y-labeled B72.3 Intraperitoneal Administration in Patients with Ovarian Cancer: Effect of Dose and EDTA Coadministration on Pharmacokinetics and Toxicity Clin. Cancer Res., May 1, 1999; 5(5): 953 - 961. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Guadagni, P. Graziano, M. Roselli, S. Mariotti, P. Bernard, P. Sinibaldi-Vallebona, G. Rasi, and E. Garaci Differential Expression of a New Tumor-Associated Antigen, TLP, During Human Colorectal Cancer Tumorigenesis Am. J. Pathol., April 1, 1999; 154(4): 993 - 999. [Abstract] [Full Text] [PDF] |
||||

